Global Post-Marketing Pharmacovigilance And Medical Information Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Post-Marketing Pharmacovigilance And Medical Information Global Market Report 2025

Name: Post-Marketing Pharmacovigilance And Medical Information Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining), By Product (Books, Online Media, Journals), By End User (Hospitals, Research Organizations, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Post-Marketing Pharmacovigilance And Medical Information Market Overview

• Post-Marketing Pharmacovigilance And Medical Information market size has reached to $6.16 billion in 2024

• Expected to grow to $10.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%

• Growth Driver: Rising Incidence Of Adverse Drug Reactions Fueling The Growth Of The Market Due To Increasing Use Of Complex Biologics And Specialty Medications

• Market Trend: AI-Powered Pharmacovigilance Solutions Driving Efficiency And Compliance In Drug Safety Monitoring

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Post-Marketing Pharmacovigilance And Medical Information Market?

Post-marketing pharmacovigilance is the continuous monitoring of a drug’s safety once it is available on the market, focusing on identifying, evaluating, and preventing adverse effects or other drug-related issues. Medical information services deliver precise, scientific, and current responses to healthcare providers and patients about a drug’s usage, safety, and effectiveness. Together, these processes safeguard patient health, ensure regulatory compliance, and enhance treatment outcomes.

The main types of post-marketing pharmacovigilance and medical information are spontaneous reporting, intensified adverse drug reaction (ADR) reporting, targeted spontaneous reporting, cohort event monitoring, and electronic health record (EHR) mining. Spontaneous reporting involves healthcare professionals or patients voluntarily noticing and communicating unexpected reactions associated with medication usage to authorized bodies. It includes product types, such as books, online media, and journals, and caters to diverse end users, including hospitals, research organizations, and others.

Post-Marketing Pharmacovigilance And Medical Information Market Size and growth rate 2025 to 2029: Graph

What Is The Post-Marketing Pharmacovigilance And Medical Information Market Size 2025 And Growth Rate?

What Is The Post-Marketing Pharmacovigilance And Medical Information Market Growth Forecast?

The post-marketing pharmacovigilance and medical information market size is expected to see rapid growth in the next few years. It will grow to $10.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to advancements in drug safety analytics tools, growing adoption of cloud-based pharmacovigilance solutions, increasing launch of novel therapeutics, rising emphasis on proactive risk management strategies, and growing pharmacovigilance requirements in emerging markets. Major trends in the forecast period include advancement in automated adverse event detection, development of integrated pharmacovigilance platforms, innovation in real-time safety data monitoring, advancement in patient engagement tools for safety reporting, and development of predictive analytics for drug risk assessment.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Post-Marketing Pharmacovigilance And Medical Information Market Segmented?

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Product: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

What Is Driving The Post-Marketing Pharmacovigilance And Medical Information Market? Rising Incidence Of Adverse Drug Reactions Fueling The Growth Of The Market Due To Increasing Use Of Complex Biologics And Specialty Medications

The rising incidence of adverse drug reactions is expected to propel the growth of the post-marketing pharmacovigilance and medical information market going forward. Adverse drug reactions refer to harmful or unintended effects that occur when a medication is taken at its recommended dosage for prevention, diagnosis, or treatment purposes. The incidence of adverse drug reactions is rising as the aging population increasingly requires treatment for multiple chronic conditions, leading to the simultaneous use of several medications that heighten the likelihood of harmful drug interactions and unexpected side effects. Post-marketing pharmacovigilance and medical information support the management of adverse drug reactions by detecting, tracking, and sharing details on potential side effects after a medicine is launched, helping maintain its safety and effectiveness. For instance, in January 2023, according to Navikenz, a US-based artificial intelligence-focused IT services company, in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, exceeding the toll from stroke and diabetes combined, with around 2.7 million cases each year resulting in over 100,000 hospitalizations and more than 15,000 deaths. Therefore, the rising incidence of adverse drug reactions is driving the growth of the post-marketing pharmacovigilance and medical information industry.

Who Are The Major Players In The Global Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.

What Are The Key Trends Of The Global Post-Marketing Pharmacovigilance And Medical Information Market? AI-Powered Pharmacovigilance Solutions Driving Efficiency And Compliance In Drug Safety Monitoring

Major companies operating in the post-marketing pharmacovigilance and medical information market are focusing on developing advanced solutions, such as AI-powered pharmacovigilance workflows, to enhance adverse event detection accuracy and enable real-time safety monitoring for better patient outcomes. AI-powered pharmacovigilance workflows use artificial intelligence to automate drug safety monitoring, enabling faster adverse event detection and improved regulatory compliance. For instance, in January 2024, PubHive Ltd., a UK-based cloud-based software-as-a-service (SaaS) company, introduced a centralized Summary of Product Characteristics (SmPC) management for life science companies and research organizations. The platform consolidates critical drug safety information into a single, easily accessible repository, automates literature monitoring and regulatory reporting, enhances team collaboration, and streamlines compliance processes through advanced AI capabilities. This enables pharmacovigilance teams to operate more efficiently and proactively, ensuring both patient safety and adherence to regulatory standards.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Post-Marketing Pharmacovigilance And Medical Information Market? Ergomed plc Acquired Panacea Pharma Projects Limited To Strengthen Primevigilance And Expand Global Reach

In October 2023, Ergomed plc, a UK-based pharmaceutical services company, acquired Panacea Pharma Projects Limited for an undisclosed amount. With this acquisition, Ergomed aims to expand its pharmacovigilance business, PrimeVigilance, strengthen its capabilities, and broaden its geographic reach, supporting its strategy to become a leading provider of pharmacovigilance services. Panacea Pharma Projects Limited is a UK-based pharmaceutical consultancy firm that specializes in pharmacovigilance (PV) and medical information services, including post-marketing support.

What Is The Regional Outlook For The Global Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market includes revenues earned by entities by providing services such as adverse event reporting and management, signal detection and risk assessment, drug safety database, medical call center services, and regulatory compliance support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Post-Marketing Pharmacovigilance And Medical Information Industry?

The post-marketing pharmacovigilance and medical information market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the post-marketing pharmacovigilance and medical information industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Post Marketing Pharmacovigilance And Medical Information Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$6.90 billion
Revenue Forecast In 2034	$10.68 billion
Growth Rate	CAGR of 11.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Type, Product, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Cencora Inc., Cardinal Health Inc., Accenture plc, Sanofi S.A., Thermo Fisher Scientific Inc., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, Laboratory Corporation of America Holdings, ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Genpact Limited, Charles River Laboratories International Inc., Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Post-Marketing Pharmacovigilance And Medical Information Market Characteristics

3. Post-Marketing Pharmacovigilance And Medical Information Market Trends And Strategies

4. Post-Marketing Pharmacovigilance And Medical Information Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Post-Marketing Pharmacovigilance And Medical Information Growth Analysis And Strategic Analysis Framework

5.1. Global Post-Marketing Pharmacovigilance And Medical Information PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Post-Marketing Pharmacovigilance And Medical Information Market Growth Rate Analysis

5.4. Global Post-Marketing Pharmacovigilance And Medical Information Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Post-Marketing Pharmacovigilance And Medical Information Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Post-Marketing Pharmacovigilance And Medical Information Total Addressable Market (TAM)

6. Post-Marketing Pharmacovigilance And Medical Information Market Segmentation

6.1. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Spontaneous Reporting

Intensified Adverse Drug Reaction (ADR) Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

Electronic Health Record (EHR) Mining

6.2. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Books

Online Media

Journals

6.3. Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Research Organizations

Other End-Users

6.4. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consumer Reporting

Healthcare Professional Reporting

Regulatory Authority Reporting

Pharmaceutical Company Reporting

Digital App-Based Reporting

6.5. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Intensified Adverse Drug Reaction (ADR) Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital-Based Surveillance

Program-Specific Monitoring

Disease-Specific Monitoring

Product-Specific Monitoring

Real-Time Monitoring Systems

6.6. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Risk Population-Based Reporting

Therapeutic Class-Based Reporting

Adverse Drug Reaction Focused Reporting

Region-Specific Reporting

Healthcare Setting-Specific Reporting

6.7. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prospective Cohort Monitoring

Retrospective Cohort Monitoring

Active Follow-Up Monitoring

New Drug User Monitoring

Disease Registry-Linked Monitoring

6.8. Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Electronic Health Record (EHR) Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Natural Language Processing-Based Mining

Artificial Intelligence (AI) And Machine Learning Algorithms

Rule-Based Signal Detection

Longitudinal Patient Data Analysis

Integrated Hospital Data Systems

7. Post-Marketing Pharmacovigilance And Medical Information Market Regional And Country Analysis

7.1. Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market

8.1. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Post-Marketing Pharmacovigilance And Medical Information Market

9.1. China Post-Marketing Pharmacovigilance And Medical Information Market Overview

9.2. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Post-Marketing Pharmacovigilance And Medical Information Market

10.1. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Post-Marketing Pharmacovigilance And Medical Information Market

11.1. Japan Post-Marketing Pharmacovigilance And Medical Information Market Overview

11.2. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Post-Marketing Pharmacovigilance And Medical Information Market

12.1. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market

13.1. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Post-Marketing Pharmacovigilance And Medical Information Market

14.1. South Korea Post-Marketing Pharmacovigilance And Medical Information Market Overview

14.2. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market

15.1. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market Overview

15.2. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Post-Marketing Pharmacovigilance And Medical Information Market

16.1. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Post-Marketing Pharmacovigilance And Medical Information Market

17.1. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Post-Marketing Pharmacovigilance And Medical Information Market

18.1. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Post-Marketing Pharmacovigilance And Medical Information Market

19.1. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Post-Marketing Pharmacovigilance And Medical Information Market

20.1. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market

21.1. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market Overview

21.2. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Post-Marketing Pharmacovigilance And Medical Information Market

22.1. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Post-Marketing Pharmacovigilance And Medical Information Market

23.1. North America Post-Marketing Pharmacovigilance And Medical Information Market Overview

23.2. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Post-Marketing Pharmacovigilance And Medical Information Market

24.1. USA Post-Marketing Pharmacovigilance And Medical Information Market Overview

24.2. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Post-Marketing Pharmacovigilance And Medical Information Market

25.1. Canada Post-Marketing Pharmacovigilance And Medical Information Market Overview

25.2. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Post-Marketing Pharmacovigilance And Medical Information Market

26.1. South America Post-Marketing Pharmacovigilance And Medical Information Market Overview

26.2. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Post-Marketing Pharmacovigilance And Medical Information Market

27.1. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Post-Marketing Pharmacovigilance And Medical Information Market

28.1. Middle East Post-Marketing Pharmacovigilance And Medical Information Market Overview

28.2. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Post-Marketing Pharmacovigilance And Medical Information Market

29.1. Africa Post-Marketing Pharmacovigilance And Medical Information Market Overview

29.2. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Post-Marketing Pharmacovigilance And Medical Information Market Competitive Landscape And Company Profiles

30.1. Post-Marketing Pharmacovigilance And Medical Information Market Competitive Landscape

30.2. Post-Marketing Pharmacovigilance And Medical Information Market Company Profiles

30.2.1. Cencora Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Accenture plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Post-Marketing Pharmacovigilance And Medical Information Market Other Major And Innovative Companies

31.1. Capgemini SE

31.2. Merck & Co. Inc.

31.3. Cognizant Technology Solutions Corporation

31.4. IQVIA Holdings Inc.

31.5. HCL Technologies Limited

31.6. Laboratory Corporation of America Holdings

31.7. ICON plc

31.8. WuXi AppTec Co. Ltd.

31.9. Syneos Health Inc.

31.10. Genpact Limited

31.11. Charles River Laboratories International Inc.

31.12. Parexel International Corporation

31.13. Avalere Health LLC

31.14. Quanticate Limited

31.15. Inizio Consulting LLC

32. Global Post-Marketing Pharmacovigilance And Medical Information Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Post-Marketing Pharmacovigilance And Medical Information Market

34. Recent Developments In The Post-Marketing Pharmacovigilance And Medical Information Market

35. Post-Marketing Pharmacovigilance And Medical Information Market High Potential Countries, Segments and Strategies

35.1 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Countries Offering Most New Opportunities

35.2 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Segments Offering Most New Opportunities

35.3 Post-Marketing Pharmacovigilance And Medical Information Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Intensified Adverse Drug Reaction (ADR) Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Electronic Health Record (EHR) Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Cencora Inc. Financial Performance

Table 80: Cardinal Health Inc. Financial Performance

Table 81: Accenture plc Financial Performance

Table 82: Sanofi S.A. Financial Performance

Table 83: Thermo Fisher Scientific Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Intensified Adverse Drug Reaction (ADR) Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Post-Marketing Pharmacovigilance And Medical Information Market, Sub-Segmentation Of Electronic Health Record (EHR) Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Post-Marketing Pharmacovigilance And Medical Information Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Post-Marketing Pharmacovigilance And Medical Information Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Cencora Inc. Financial Performance

Figure 80: Cardinal Health Inc. Financial Performance

Figure 81: Accenture plc Financial Performance

Figure 82: Sanofi S.A. Financial Performance

Figure 83: Thermo Fisher Scientific Inc. Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Dry Construction Global Market Report 2025 – By Type (Supporting Framework, Boarding), By Material (Plasterboard, Wood, Metal, Plastic), By System (Ceiling System, Wall System, Flooring System), By Application (Residenti...

Cladding Systems Global Market Report 2025 – By Material (Steel, Aluminum, Zinc, Copper, Plastic Panels), By Application (Walls, Roofs), By End User (Residential Buildings, Non-Residential Buildings) – Impact of Tariff a...

Drain Cleaning Equipment Global Market Report 2025 – By Type (Hand Tool, Sink Machine, Sectional Machines, Rodders, Jetters, Push-Rod Camera, Locating Equipment, Flexible Shaft Machine, Drum Or Continuous Cable Machine),...

Urinary Drainage Bags Global Market Report 2025 – By Product (Large Bags, Leg Bags), By Usage (Reusable, Disposable), By Capacity (0-500 ml, 500-1000 ml, 1000-2000 ml), By End-Use (Hospital, Clinics, Other End-Users) – I...

Prefabricated Buildings Global Market Report 2025 – By Product (Skeleton System, Panel System, Cellular System, Combined System), By Material (Concrete, Glass, Metal, Timber, Other Materials), By Module Type (Bathroom Po...

Medical And Surgical Drainage System Global Market Report 2025 – By Product Type (Drainage Systems, Accessories), By Material Type (Silastic, Rubber, Other Materials), By Flow Type (Active, Passive), By Application (Card...

Ostomy Drainage Bags Global Market Report 2025 – By Type( Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Ileostomy Bags, Continent Urostomy Bags), By Clinical Application( Colorectal Cancer, Bladder Cancer, Col...

Frequently Asked Questions

What is the definition of the Post Marketing Pharmacovigilance And Medical Information market?

How will the Post Marketing Pharmacovigilance And Medical Information market drivers and restraints affect the market dynamics? What forces will shape the Post Marketing Pharmacovigilance And Medical Information industry going forward?

The market major growth driver - Rising Incidence Of Adverse Drug Reactions Fueling The Growth Of The Market Due To Increasing Use Of Complex Biologics And Specialty Medications. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Post Marketing Pharmacovigilance And Medical Information market?

The post-marketing pharmacovigilance and medical information market size has grown rapidly in recent years. It will grow from $6.16 billion in 2024 to $6.90 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to growing integration of AI in pharmacovigilance processes, increasing demand for outsourced drug safety services, rising complexity of biopharmaceutical products, growing focus on patient-reported outcomes, and increasing collaboration between regulatory agencies and industry. The post-marketing pharmacovigilance and medical information market size is expected to see rapid growth in the next few years. It will grow to $10.68 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to advancements in drug safety analytics tools, growing adoption of cloud-based pharmacovigilance solutions, increasing launch of novel therapeutics, rising emphasis on proactive risk management strategies, and growing pharmacovigilance requirements in emerging markets. Major trends in the forecast period include advancement in automated adverse event detection, development of integrated pharmacovigilance platforms, innovation in real-time safety data monitoring, advancement in patient engagement tools for safety reporting, and development of predictive analytics for drug risk assessment. For further insights on this market, request a sample here

How is the Post Marketing Pharmacovigilance And Medical Information market segmented?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented
1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining
2) By Product: Books, Online Media, Journals
3) By End User: Hospitals, Research Organizations, Other End-Users Subsegments:
1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting
2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems
3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting
4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring
5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems For further insights on this market, request a sample here

Which region has the largest share of the Post Marketing Pharmacovigilance And Medical Information market? What are the other regions covered in the report?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Post Marketing Pharmacovigilance And Medical Information market?

What are the key trends in the Post Marketing Pharmacovigilance And Medical Information market?

Major trends in this market include AI-Powered Pharmacovigilance Solutions Driving Efficiency And Compliance In Drug Safety Monitoring. For further insights on this market, request a sample here.